ATE126533T1 - Plasmid zur herstellung von membranprotein, dieses plasmid enthaltendes bakterium, monoklonaler antikörper hierfür und verfahren zur identifikation von hämophilus influenzae. - Google Patents

Plasmid zur herstellung von membranprotein, dieses plasmid enthaltendes bakterium, monoklonaler antikörper hierfür und verfahren zur identifikation von hämophilus influenzae.

Info

Publication number
ATE126533T1
ATE126533T1 AT87116699T AT87116699T ATE126533T1 AT E126533 T1 ATE126533 T1 AT E126533T1 AT 87116699 T AT87116699 T AT 87116699T AT 87116699 T AT87116699 T AT 87116699T AT E126533 T1 ATE126533 T1 AT E126533T1
Authority
AT
Austria
Prior art keywords
plasmid
membrane protein
haemophilus influenzae
bacterium containing
immunogenic portion
Prior art date
Application number
AT87116699T
Other languages
English (en)
Inventor
Timothy F Murphy
Michael A Apicella
Original Assignee
Univ New York State Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York State Res Found filed Critical Univ New York State Res Found
Application granted granted Critical
Publication of ATE126533T1 publication Critical patent/ATE126533T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1242—Gram-negative bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/285—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Pasteurellaceae (F), e.g. Haemophilus influenza
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/961—Chemistry: molecular biology and microbiology including a step of forming, releasing, or exposing the antigen or forming the hapten-immunogenic carrier complex or the antigen per se
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/972—Modified antibody, e.g. hybrid, bifunctional

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Virology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AT87116699T 1986-11-18 1987-11-12 Plasmid zur herstellung von membranprotein, dieses plasmid enthaltendes bakterium, monoklonaler antikörper hierfür und verfahren zur identifikation von hämophilus influenzae. ATE126533T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US93287286A 1986-11-18 1986-11-18
US07/092,948 US5173294A (en) 1986-11-18 1987-10-08 Dna probe for the identification of haemophilus influenzae

Publications (1)

Publication Number Publication Date
ATE126533T1 true ATE126533T1 (de) 1995-09-15

Family

ID=26786217

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87116699T ATE126533T1 (de) 1986-11-18 1987-11-12 Plasmid zur herstellung von membranprotein, dieses plasmid enthaltendes bakterium, monoklonaler antikörper hierfür und verfahren zur identifikation von hämophilus influenzae.

Country Status (8)

Country Link
US (1) US5173294A (de)
EP (1) EP0281673B1 (de)
JP (1) JP2770877B2 (de)
AT (1) ATE126533T1 (de)
DE (1) DE3751467T2 (de)
DK (1) DK173205B1 (de)
ES (1) ES2077557T3 (de)
IE (1) IE71224B1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2534529B2 (ja) * 1986-07-24 1996-09-18 ブリティシュ・テレコミュニケ−ションズ・パブリック・リミテッド・カンパニ 放射発生器
US4862342A (en) * 1987-12-03 1989-08-29 Sundstrand Corp. DC to AC inverter with neutral having a resonant circuit
DE69033600T2 (de) * 1989-03-09 2001-04-05 American Cyanamid Co., Madison Verfahren zur Isolierung von Haemopnilus influenzae Protein-E
SE466259B (sv) 1990-05-31 1992-01-20 Arne Forsgren Protein d - ett igd-bindande protein fraan haemophilus influenzae, samt anvaendning av detta foer analys, vacciner och uppreningsaendamaal
ES2131066T3 (es) * 1990-12-21 1999-07-16 Antex Biolog Inc Vacuna de conjugacion de oligosacarido con adhesina para hi(haemophilus influenzae).
US5843463A (en) * 1990-12-21 1998-12-01 Antexbiologics, Inc. Adhesin-oligosaccharide conjugate vaccine for Haemophilus influenzae
GB9202219D0 (en) * 1992-02-03 1992-03-18 Connaught Lab A synthetic heamophilus influenzae conjugate vaccine
GB9224584D0 (en) * 1992-11-23 1993-01-13 Connaught Lab Use of outer membrane protein d15 and its peptides as vaccine against haempohilus influenzae diseases
US6153406A (en) * 1993-07-23 2000-11-28 North American Vaccine, Inc. Method for the high level expression, purification and refolding of the outer membrane protein P2 from Haemophilus influenzae type B
US5681570A (en) * 1995-01-12 1997-10-28 Connaught Laboratories Limited Immunogenic conjugate molecules
WO1999050402A1 (en) * 1998-03-27 1999-10-07 President And Fellows Of Harvard College Systematic identification of essential genes by in vitro transposon mutagenesis
GB9809683D0 (en) * 1998-05-06 1998-07-01 Smithkline Beecham Biolog Novel compounds
ATE459373T1 (de) 1999-03-19 2010-03-15 Glaxosmithkline Biolog Sa Impfstoff gegen kapsulare polysaccharide von streptococcus pneumoniae
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
GB0025486D0 (en) * 2000-10-17 2000-11-29 Smithkline Beecham Biolog Novel compounds
GB0103171D0 (en) 2001-02-08 2001-03-28 Smithkline Beecham Biolog Vaccine composition
US20060057160A1 (en) 2002-08-02 2006-03-16 Ralph Biemans Vaccine composition
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
KR101515078B1 (ko) 2005-12-22 2015-04-24 글락소스미스클라인 바이오로지칼즈 에스.에이. 백신
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
MY150105A (en) 2006-01-17 2013-11-29 Forsgren Arne A novel surface exposed haemophilus influenzae protein (protein e; pe)
CA2690708A1 (en) 2007-06-26 2008-12-31 Glaxosmithkline Biologicals S.A. Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
GB201003922D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Conjugation process
CA2792687A1 (en) 2010-03-10 2011-09-15 Glaxosmithkline Biologicals S.A. Immunogenic composition
GB201103836D0 (en) 2011-03-07 2011-04-20 Glaxosmithkline Biolog Sa Conjugation process
CA2838188C (en) * 2011-06-04 2017-04-18 Rochester General Hospital Research Institute Compositions and methods related to p6 of haemophilus influenzae
JP6311959B2 (ja) * 2012-10-04 2018-04-18 国立大学法人三重大学 微生物の迅速診断を可能とする特異抗体の高効率作製法
CN105242040B (zh) * 2014-08-18 2017-01-18 董俊 人流感嗜血杆菌量子点免疫层析检测卡及其制备方法和应用
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
GB2600653B (en) 2017-05-30 2022-11-02 Glaxosmithkline Biologicals Sa Novel methods
BR112020010790A2 (pt) 2017-12-01 2020-11-10 Glaxosmithkline Biologicals S.A. purificação da saponina
EP3833382A1 (de) 2018-08-07 2021-06-16 GlaxoSmithKline Biologicals S.A. Verfahren und impfstoffe
EP3886901A1 (de) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Verfahren zur herstellung eines adjuvans
WO2020245207A1 (en) 2019-06-05 2020-12-10 Glaxosmithkline Biologicals Sa Saponin purification
GB202205833D0 (en) 2022-04-21 2022-06-08 Glaxosmithkline Biologicals Sa Bacteriophage
EP4558170A1 (de) 2022-07-19 2025-05-28 GlaxoSmithKline Biologicals S.A. Kontinuierliches verfahren zur herstellung von impfstoffen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4496538A (en) * 1982-07-06 1985-01-29 Connaught Laboratories, Inc. Haemophilus influenzae b polysaccharide-diphtheria toxoid conjugate vaccine
JPH0671067B2 (ja) * 1985-11-20 1994-09-07 株式会社日立製作所 半導体装置

Also Published As

Publication number Publication date
DK602087D0 (da) 1987-11-17
ES2077557T3 (es) 1995-12-01
IE71224B1 (en) 1997-02-12
JP2770877B2 (ja) 1998-07-02
US5173294A (en) 1992-12-22
EP0281673A1 (de) 1988-09-14
DE3751467T2 (de) 1996-02-15
JPH01157387A (ja) 1989-06-20
DE3751467D1 (de) 1995-09-21
DK602087A (da) 1988-05-19
EP0281673B1 (de) 1995-08-16
DK173205B1 (da) 2000-03-13
IE873051L (en) 1988-05-18

Similar Documents

Publication Publication Date Title
ATE126533T1 (de) Plasmid zur herstellung von membranprotein, dieses plasmid enthaltendes bakterium, monoklonaler antikörper hierfür und verfahren zur identifikation von hämophilus influenzae.
DE69739981D1 (de) Streptococcus pneumoniae-Antigene und Impfstoffe
ATE83801T1 (de) Verfahren und mittel zur herstellung eines proteins mit der gleichen igg-spezifizitaet wie protein g.
KR870010189A (ko) HTLV-Ⅲgag/ env 유전자 단백질의 발현 및 정제
UA42668C2 (uk) Поліпептид, що має антигенні властивості вірусу гепатиту с (hcv) (варіанти), діагностичний реагент для виявлення антитіл до вірусу гепатиту с (варіанти), набір для виявлення антитіл до вірусу гепатиту с (варіанти), спосіб виявлення антитіл до вірусу гепатиту с (варіанти)
AU7532887A (en) Diagnosis method for detection of b-cell neoplasms
ATE141956T1 (de) Verfahren zur vervielfältigung von nukleinsäuresequenzen
AU7158796A (en) Compounds and methods for diagnosis of tuberculosis
DK1114864T4 (da) Pattedyrcelleoverfladeantigener samt tilhørende reagenser
FI895050A0 (fi) Diagnostiska preparat och vaccin foer mykobakterier i folkhaelso-, medicinsk och veterinaermedicinsk praxis.
DE3587422D1 (de) Fuer ein hirudinaehnliches protein kodierende dns-sequenz und verfahren zur herstellung eines solchen proteins.
KR910012244A (ko) 톡소플라스마 곤디 항원, 이의 제조방법 및 이의 용도
RU97100934A (ru) Нуклеотидные последовательности пестивирусных штаммов, полипептиды, закодированные этими последовательностями, и их использование для диагностики и профилактики пестивирусных инфекций
Kaufhold et al. M protein gene typing of Streptococcus pyogenes by nonradioactively labeled oligonucleotide probes
DE3752131D1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
BR9713450A (pt) Quimiocinas de mamìfero
DE3776525D1 (de) Immunochemisches verfahren zur bestimmung von stabilem glykosiliertem haemoglobin.
AU8503898A (en) Monospecific antibody reactive with fibrinogen and fibrinopeptide
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
EP0276984A3 (de) Bestimmung von Anti-DNS-Antikörpern
ATE31733T1 (de) Verfahren zur herstellung von hybridisierungssonden.
PORTIER et al. Translation in vitro of Tetrahymena pyriformis Polyadenylated mRNA: Identification of Tubulin amongst the Translated Products and Demonstration of Its Heterogeneity
EP0366813A4 (en) Method for diagnosis of infectious diseases and method of detecting and identifying microorganisms
ATE107033T1 (de) Nachweis von tumorassozierten anzeigern in biologischen flüssigkeiten.
Brown et al. Comparative analyses of vesiculovirus proteins utilizing partial cleavage fragments at tryptophan residues

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time